The agency warned that adults and children who inadvertently took a higher dose of clonazepam than prescribed could experience side effects, including “significant” sedation, confusion, dizziness, diminished reflexes, the loss of muscle control and muscle weakness.

"Children and adults who inadvertently consume a higher dose of clonazepam could be at increased risk for the adverse events of significant sedation, confusion, dizziness, diminis

Clonazepam, an anxiety drug, has been recalled because of a labeling error that could result in harmful consequences.

Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life-threatening consequences.

A popular anxiety drug is being recalled over a ‘life-threatening’ label mistake. In a recall alert for certain lots of Clonazepam Orally Disintegrating Tablets, the company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.

The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.

Drug manufacturer Endo announced on Friday that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, a popular anxiety drug,

A popular prescription anxiety drug is being recalled nationwide for a “possibly life-threatening” mistake on the carton. The Pennsylvania-based drug maker Endo announced this week that it is expanding its recall of clonazepam tablets because some cartons bear the incorrect drug strength and wrong drug code.

A widely used anxiety medication taken by nearly 2 million Americans is being recalled nationwide due to a 'life-threatening' labeling error. The recall affects 16 lots of clonazepam, an anti-anxiety drug sold under the brand name Par Pharmaceutical.